只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-27 2026-07-29 | MLTX MoonLake Immunotherapeutics | Reich Kristian Officer · Chief Scientific Officer | 卖出（S） | 1,100 | US$20.00 | US$22,000.00 | 2,711,198 | SEC |
| 2026-07-22 2026-07-23 | MLTX MoonLake Immunotherapeutics | Reich Kristian Officer · Chief Scientific Officer | 卖出（S） | 2,448 | US$20.00 | US$48,960.00 | 2,712,298 | SEC |
| 2026-07-21 2026-07-23 | MLTX MoonLake Immunotherapeutics | Reich Kristian Officer · Chief Scientific Officer | 卖出（S） | 50,000 | US$20.02 | US$100.1万 | 2,714,746 | SEC |
| 2026-07-20 2026-07-21 | MLTX MoonLake Immunotherapeutics | Reich Kristian Officer · Chief Scientific Officer | 卖出（S） | 43,700 | US$20.09 | US$877,933.00 | 2,764,746 | SEC |
| 2026-07-15 2026-07-20 | MLTX MoonLake Immunotherapeutics | Reich Kristian Officer · Chief Scientific Officer | 卖出（S） | 16,105 | US$20.01 | US$322,261.05 | 2,808,446 | SEC |
| 2026-07-10 2026-07-13 | MLTX MoonLake Immunotherapeutics | Santos da Silva Jorge Director,Officer · Chief Executive Officer | 卖出（S） | 68,289 | US$20.02 | US$136.71万 | 2,774,893 | SEC |
| 2026-07-09 2026-07-13 | MLTX MoonLake Immunotherapeutics | Santos da Silva Jorge Director,Officer · Chief Executive Officer | 卖出（S） | 33,936 | US$20.01 | US$679,059.36 | 2,843,182 | SEC |
| 2026-07-01 2026-07-02 | MLTX MoonLake Immunotherapeutics | Santos da Silva Jorge Director,Officer · Chief Executive Officer | 卖出（S） | 47,775 | US$20.03 | US$956,933.25 | 2,877,118 | SEC |
| 2026-06-22 2026-06-23 | MLTX MoonLake Immunotherapeutics | Bodenstedt Matthias Officer · Chief Financial Officer | 卖出（S） | 39,120 | US$22.04 | US$862,204.80 | 1,115,435 | SEC |
| 2026-06-18 2026-06-18 | MLTX MoonLake Immunotherapeutics | Bodenstedt Matthias Officer · Chief Financial Officer | 卖出（S） | 2,794 | US$19.60 | US$54,762.40 | 1,154,555 | SEC |
| 2026-06-17 2026-06-18 | MLTX MoonLake Immunotherapeutics | Bodenstedt Matthias Officer · Chief Financial Officer | 卖出（S） | 15,082 | US$19.68 | US$296,813.76 | 1,157,349 | SEC |
| 2026-06-17 2026-06-17 | MLTX MoonLake Immunotherapeutics | Reich Kristian Officer · Chief Scientific Officer | 卖出（S） | 50,000 | US$19.43 | US$971,500.00 | 2,824,551 | SEC |
| 2026-06-16 2026-06-17 | MLTX MoonLake Immunotherapeutics | Reich Kristian Officer · Chief Scientific Officer | 卖出（S） | 50,000 | US$18.70 | US$935,000.00 | 2,874,551 | SEC |
| 2026-06-15 2026-06-17 | MLTX MoonLake Immunotherapeutics | Reich Kristian Officer · Chief Scientific Officer | 卖出（S） | 50,000 | US$18.89 | US$944,500.00 | 2,924,551 | SEC |
| 2026-05-11 2026-05-13 | MLTX MoonLake Immunotherapeutics | Bodenstedt Matthias Officer · Chief Financial Officer | 卖出（S） | 13,653 | US$20.02 | US$273,333.06 | 1,172,431 | SEC |
| 2026-04-14 2026-04-16 | MLTX MoonLake Immunotherapeutics | Bodenstedt Matthias Officer · Chief Financial Officer | 卖出（S） | 2,426 | US$19.56 | US$47,452.56 | 1,186,084 | SEC |
| 2026-04-13 2026-04-14 | MLTX MoonLake Immunotherapeutics | Santos da Silva Jorge Director,Officer · Chief Executive Officer | 卖出（S） | 51,873 | US$18.23 | US$945,644.79 | 2,924,893 | SEC |
| 2026-04-10 2026-04-14 | MLTX MoonLake Immunotherapeutics | Santos da Silva Jorge Director,Officer · Chief Executive Officer | 卖出（S） | 98,127 | US$18.41 | US$180.65万 | 2,976,766 | SEC |
| 2026-04-10 2026-04-10 | MLTX MoonLake Immunotherapeutics | Bodenstedt Matthias Officer · Chief Financial Officer | 卖出（S） | 1,925 | US$19.51 | US$37,556.75 | 1,188,510 | SEC |
| 2026-04-09 2026-04-10 | MLTX MoonLake Immunotherapeutics | Bodenstedt Matthias Officer · Chief Financial Officer | 卖出（S） | 85,870 | US$18.94 | US$162.64万 | 1,190,435 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | LAMPERT MARK N Director,TenPercentOwner | 卖出（S） | 1,932,354 | US$16.79 | US$3244.42万 | 8,302,735 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF II GP LLC Director,TenPercentOwner | 卖出（S） | 1,932,354 | US$16.79 | US$3244.42万 | 8,302,735 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BIOTECHNOLOGY VALUE FUND L P Director,TenPercentOwner | 卖出（S） | 1,932,354 | US$16.79 | US$3244.42万 | 8,302,735 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF Partners OS Ltd. Director,Other | 卖出（S） | 1,932,354 | US$16.79 | US$3244.42万 | 8,302,735 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF INC/IL Director,TenPercentOwner | 卖出（S） | 1,932,354 | US$16.79 | US$3244.42万 | 8,302,735 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | Biotechnology Value Trading Fund OS LP Director,Other | 卖出（S） | 1,932,354 | US$16.79 | US$3244.42万 | 8,302,735 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF I GP LLC Director,TenPercentOwner | 卖出（S） | 1,932,354 | US$16.79 | US$3244.42万 | 8,302,735 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF PARTNERS L P/IL Director,TenPercentOwner | 卖出（S） | 1,932,354 | US$16.79 | US$3244.42万 | 8,302,735 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BIOTECHNOLOGY VALUE FUND II LP Director,TenPercentOwner | 卖出（S） | 1,932,354 | US$16.79 | US$3244.42万 | 8,302,735 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF GP HOLDINGS LLC Director,TenPercentOwner | 卖出（S） | 1,932,354 | US$16.79 | US$3244.42万 | 8,302,735 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | LAMPERT MARK N Director,TenPercentOwner | 卖出（S） | 1,569,116 | US$16.79 | US$2634.55万 | 6,599,722 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF II GP LLC Director,TenPercentOwner | 卖出（S） | 1,569,116 | US$16.79 | US$2634.55万 | 6,599,722 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BIOTECHNOLOGY VALUE FUND L P Director,TenPercentOwner | 卖出（S） | 1,569,116 | US$16.79 | US$2634.55万 | 6,599,722 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF Partners OS Ltd. Director,Other | 卖出（S） | 1,569,116 | US$16.79 | US$2634.55万 | 6,599,722 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF INC/IL Director,TenPercentOwner | 卖出（S） | 1,569,116 | US$16.79 | US$2634.55万 | 6,599,722 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | Biotechnology Value Trading Fund OS LP Director,Other | 卖出（S） | 1,569,116 | US$16.79 | US$2634.55万 | 6,599,722 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF I GP LLC Director,TenPercentOwner | 卖出（S） | 1,569,116 | US$16.79 | US$2634.55万 | 6,599,722 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF PARTNERS L P/IL Director,TenPercentOwner | 卖出（S） | 1,569,116 | US$16.79 | US$2634.55万 | 6,599,722 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BIOTECHNOLOGY VALUE FUND II LP Director,TenPercentOwner | 卖出（S） | 1,569,116 | US$16.79 | US$2634.55万 | 6,599,722 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF GP HOLDINGS LLC Director,TenPercentOwner | 卖出（S） | 1,569,116 | US$16.79 | US$2634.55万 | 6,599,722 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | LAMPERT MARK N Director,TenPercentOwner | 卖出（S） | 248,530 | US$16.79 | US$417.28万 | 1,039,238 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF II GP LLC Director,TenPercentOwner | 卖出（S） | 248,530 | US$16.79 | US$417.28万 | 1,039,238 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BIOTECHNOLOGY VALUE FUND L P Director,TenPercentOwner | 卖出（S） | 248,530 | US$16.79 | US$417.28万 | 1,039,238 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF Partners OS Ltd. Director,Other | 卖出（S） | 248,530 | US$16.79 | US$417.28万 | 1,039,238 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF INC/IL Director,TenPercentOwner | 卖出（S） | 248,530 | US$16.79 | US$417.28万 | 1,039,238 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | Biotechnology Value Trading Fund OS LP Director,Other | 卖出（S） | 248,530 | US$16.79 | US$417.28万 | 1,039,238 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF I GP LLC Director,TenPercentOwner | 卖出（S） | 248,530 | US$16.79 | US$417.28万 | 1,039,238 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF PARTNERS L P/IL Director,TenPercentOwner | 卖出（S） | 248,530 | US$16.79 | US$417.28万 | 1,039,238 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BIOTECHNOLOGY VALUE FUND II LP Director,TenPercentOwner | 卖出（S） | 248,530 | US$16.79 | US$417.28万 | 1,039,238 | SEC |
| 2026-03-31 2026-04-02 | MLTX MoonLake Immunotherapeutics | BVF GP HOLDINGS LLC Director,TenPercentOwner | 卖出（S） | 248,530 | US$16.79 | US$417.28万 | 1,039,238 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| MLTX | 144,157.6883 | 224 | 275,903.5013 | 52.25% | B, Q, N |